BANK OF MONTREAL /CAN/ - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 96 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$2,819,000
-16.0%
49,480
-5.6%
0.00%
-33.3%
Q2 2020$3,357,000
+16.6%
52,429
+1.9%
0.00%0.0%
Q1 2020$2,879,000
-1.1%
51,470
+0.6%
0.00%
+50.0%
Q4 2019$2,912,000
+242.6%
51,147
+222.2%
0.00%
+100.0%
Q3 2019$850,000
+462.9%
15,874
+533.4%
0.00%
Q2 2019$151,000
-52.4%
2,506
-50.6%
0.00%
Q1 2019$317,000
-0.9%
5,071
-4.2%
0.00%
Q4 2018$320,000
-1.2%
5,291
-4.4%
0.00%
Q3 2018$324,000
+33.3%
5,535
+2.2%
0.00%
Q2 2018$243,000
+1.2%
5,416
-0.2%
0.00%
Q1 2018$240,000
+3.4%
5,426
+1.0%
0.00%
Q4 2017$232,000
-10.1%
5,371
-3.0%
0.00%
Q3 2017$258,000
-25.4%
5,537
-21.0%
0.00%
Q2 2017$346,000
-13.1%
7,006
-3.7%
0.00%
Q1 2017$398,000
+22.5%
7,272
+10.6%
0.00%
Q4 2016$325,000
+157.9%
6,573
+138.3%
0.00%
Q3 2016$126,000
-17.1%
2,758
-27.7%
0.00%
Q2 2016$152,000
+15.2%
3,814
+0.3%
0.00%
Q1 2016$132,000
-19.5%
3,8010.0%0.00%
Q4 2015$164,000
+37.8%
3,801
+38.9%
0.00%
Q3 2015$119,000
-33.1%
2,736
-20.7%
0.00%
Q2 2015$178,000
+117.1%
3,450
+65.1%
0.00%
Q1 2015$82,000
-23.4%
2,090
-24.6%
0.00%
Q4 2014$107,000
+12.6%
2,771
+3.1%
0.00%
Q3 2014$95,000
-5.9%
2,687
-28.1%
0.00%
Q2 2014$101,000
+6.3%
3,739
+2.0%
0.00%
Q1 2014$95,000
+18.8%
3,664
-1.2%
0.00%
Q4 2013$80,000
+110.5%
3,708
+90.3%
0.00%
Q3 2013$38,000
+26.7%
1,9490.0%0.00%
Q2 2013$30,0001,9490.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q4 2016
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 36,000$2,244,0002.71%
JW Asset Management, LLC 73,649$4,591,0002.36%
THB ASSET MANAGEMENT 87,491$5,453,0000.79%
RICE HALL JAMES & ASSOCIATES, LLC 315,972$19,695,0000.63%
EAM Global Investors LLC 22,789$1,420,0000.63%
Elk Creek Partners, LLC 73,936$4,608,0000.33%
Matarin Capital Management, LLC 69,964$4,361,0000.32%
EAM Investors, LLC 17,696$1,103,0000.27%
CADENCE CAPITAL MANAGEMENT LLC 37,196$2,318,0000.21%
Cavalier Investments, LLC 7,800$486,0000.20%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders